TuisBIIB34 • BVMF
add
Biogen Inc BDR
Vorige sluiting
R$144,30
Jaarwisseling
R$145,44 - R$214,94
Markkapitalisasie
20,55 mjd USD
Gemiddelde volume
13,00
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 2,47 mjd | -2,55% |
Bedryfskoste | 1,32 mjd | -17,78% |
Netto inkomste | 388,50 m | 670,48% |
Netto winsgrens | 15,76 | 685,87% |
Wins per aandeel | 4,08 | -6,42% |
EBITDA | 694,20 m | 75,52% |
Effektiewe belastingkoers | 13,86% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 1,70 mjd | -25,73% |
Totale bates | 28,31 mjd | 0,43% |
Totale aanspreeklikheid | 11,95 mjd | -12,83% |
Totale ekwiteit | 16,36 mjd | — |
Uitstaande aandele | 145,72 m | — |
Prys om te bespreek | 1,29 | — |
Opbrengs op bates | 4,64% | — |
Opbrengs op kapitaal | 5,61% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 388,50 m | 670,48% |
Kontant van bedrywe | 935,60 m | 57,93% |
Kontant van beleggings | -1,18 mjd | 32,21% |
Kontant van finansiering | -6,60 m | -100,78% |
Netto kontantverandering | -209,70 m | 36,44% |
Beskikbare kontantvloei | 997,75 m | 617,87% |
Meer oor
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Sweden, and Switzerland. Wikipedia
Gestig
1978
Webwerf
Werknemers
7 570
